跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anezal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Anezal
Approved
STANDARD
Anezal
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e772a62c321f981c
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
e772a62c321f981c
Drug Approval Philippines Name
Anezal
Product Name
Anezal
Registration Number
DRP-14170-03
Brand Name
Anezal
Generic Name
Enzalutamide
Dosage Form
Capsule
Dosage Strength
40 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
One Pharma Marketing Inc
Issuance Date
27 September 2024
Expiry Date
01 August 2028
Pharmacologic Category
Androgen Receptor Antagonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e772a62c321f981c
Type
Standard
Back to Philippines FDA Approvals